Literature DB >> 8054250

Dose-related effects of ibuprofen on pain-related potentials.

G Kobal1, C Hummel, M Gruber, G Geisslinger, T Hummel.   

Abstract

1. The aim of this study was to investigate the dose-related effects of ibuprofen (placebo, 400 and 800 mg rac-ibuprofen [Aktren], administered orally) on experimentally-induced tonic and phasic pain. 2. Eighteen volunteers participated in this randomized, double-blind, three-fold cross-over study. Measurements were obtained before and 90 min after administration of the drugs. Phasic pain was produced by CO2 pulses of two concentrations applied to the right nostril. The left nostril was stimulated with a constant stream of dry air which produced a tonic painful sensation described as dull and burning. Subjects rated the intensity of the painful stimuli by means of visual analogue scales. In addition, chemo-somatosensory event-related potentials (CSSERP) were also recorded in response to phasic painful CO2 stimuli. 3. While mean intensity estimates of both tonic and phasic painful stimuli showed a non-significant dose-related decrease, a statistically significant dose-related decrease was observed for CSSERP amplitudes. 4. In conclusion, in order to investigate analgesic drug effects, CSSERP appear to be a more sensitive measure compared with psychophysically obtained responses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8054250      PMCID: PMC1364900          DOI: 10.1111/j.1365-2125.1994.tb05712.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  20 in total

1.  NARCOTIC AND NON-NARCOTIC ANALGESICS WHICH BLOCK VISCERAL PAIN EVOKED BY INTRA-ARTERIAL INJECTION OF BRADYKININ AND OTHER ALGESIC AGENTS.

Authors:  F GUZMAN; C BRAUN; R K LIM; G D POTTER; D W RODGERS
Journal:  Arch Int Pharmacodyn Ther       Date:  1964-06-01

2.  Cortical responses to painful CO2 stimulation of nasal mucosa; a magnetoencephalographic study in man.

Authors:  J Huttunen; G Kobal; E Kaukoranta; R Hari
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1986-10

3.  First pain event related potentials to argon laser stimuli: recording and quantification.

Authors:  L Arendt-Nielsen
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-05       Impact factor: 10.154

4.  Late somatosensory evoked cerebral potentials in response to cutaneous heat stimuli.

Authors:  R D Treede; S Kief; T Hölzer; B Bromm
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1988-11

5.  High-performance liquid chromatographic determination of ibuprofen, its metabolites and enantiomers in biological fluids.

Authors:  G Geisslinger; K Dietzel; D Loew; O Schuster; G Rau; G Lachmann; K Brune
Journal:  J Chromatogr       Date:  1989-06-30

6.  Imipramine reduces experimental pain.

Authors:  B Bromm; W Meier; E Scharein
Journal:  Pain       Date:  1986-05       Impact factor: 6.961

7.  The correlation between blood levels of ibuprofen and clinical analgesic response.

Authors:  E M Laska; A Sunshine; I Marrero; N Olson; C Siegel; N McCormick
Journal:  Clin Pharmacol Ther       Date:  1986-07       Impact factor: 6.875

8.  Effects of pentazocine and acetylsalicylic acid on pain-rating, pain-related evoked potentials and vigilance in relationship to pharmacokinetic parameters.

Authors:  G Kobal; C Hummel; B Nuernberg; K Brune
Journal:  Agents Actions       Date:  1990-03

9.  Therapeutically relevant differences in the pharmacokinetical and pharmaceutical behavior of ibuprofen lysinate as compared to ibuprofen acid.

Authors:  G Geisslinger; K Dietzel; H Bezler; B Nuernberg; K Brune
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1989-07

10.  Brain evoked potentials are functional correlates of induced pain in man.

Authors:  Andrew C N Chen; Richard C Chapman; Stephen W Harkins
Journal:  Pain       Date:  1979-06       Impact factor: 6.961

View more
  10 in total

1.  [Non-steroidal anti-inflammatory drugs (NSAIDs): Antirheumatic, anti-pyretic or analgesic drugs?].

Authors:  K Brune
Journal:  Schmerz       Date:  1995-07       Impact factor: 1.107

2.  Effects of peripherally and centrally acting analgesics on somato-sensory evoked potentials.

Authors:  U J Moore; V R Marsh; C H Ashton; R A Seymour
Journal:  Br J Clin Pharmacol       Date:  1995-08       Impact factor: 4.335

3.  Analgesic effects of propyphenazone in comparison to its combination with caffeine.

Authors:  H G Kraetsch; T Hummel; J Lötsch; R Kussat; G Kobal
Journal:  Eur J Clin Pharmacol       Date:  1996       Impact factor: 2.953

4.  Intranasal trigeminal sensitivity in subjects with allergic rhinitis.

Authors:  H Doerfler; T Hummel; L Klimek; G Kobal
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-06-23       Impact factor: 2.503

5.  Tonic versus phasic pain: dose-related effects of ketoprofen.

Authors:  T Hummel; H Huber; S Menzel; G Kobal
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

6.  Effects of azapropazone on pain-related brain activity in human subjects.

Authors:  J Lötsch; P Mohammadian; T Hummel; S Florin; K Brune; G Geisslinger; G Kobal
Journal:  Br J Clin Pharmacol       Date:  1995-12       Impact factor: 4.335

Review 7.  Electroencephalography and analgesics.

Authors:  Lasse Paludan Malver; Anne Brokjaer; Camilla Staahl; Carina Graversen; Trine Andresen; Asbjørn Mohr Drewes
Journal:  Br J Clin Pharmacol       Date:  2014-01       Impact factor: 4.335

8.  Effects of flurbiprofen enantiomers on pain-related chemo-somatosensory evoked potentials in human subjects.

Authors:  J Lötsch; G Geisslinger; P Mohammadian; K Brune; G Kobal
Journal:  Br J Clin Pharmacol       Date:  1995-10       Impact factor: 4.335

Review 9.  Assessing efficacy of non-opioid analgesics in experimental pain models in healthy volunteers: an updated review.

Authors:  Camilla Staahl; Anne Estrup Olesen; Trine Andresen; Lars Arendt-Nielsen; Asbjørn Mohr Drewes
Journal:  Br J Clin Pharmacol       Date:  2009-09       Impact factor: 4.335

10.  Tonic stimulation of the pharyngeal mucosa causes pain and a reversible increase of inflammatory mediators.

Authors:  Bertold Renner; Gabi Ahne; Elke Grosan; Birgit Kettenmann; Gerd Kobal; Adrian Shephard
Journal:  Inflamm Res       Date:  2013-09-15       Impact factor: 4.575

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.